Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine

Laboratory Investigation

Volumn 80, Issue 2, 2000, Pages 187-197

  Lewis, William ^a,d   Grupp, Ingrid L ^a   Grupp, Günter ^a   Hoit, Brian ^a   Morris, Randal ^a   Samarel, Allen M ^b   Bruggeman, Leslie ^c   Klotman, Paul ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NATRIURETIC FACTOR; SODIUM CALCIUM EXCHANGE PROTEIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0034007233     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780022     Document Type: Article

References (49)

1. Anderson D, Virmani R, Reilly JM, O'Leary T, Cunnion RE, Robinowitz M, Macher AM, Punja U, Villaflor ST, Parrillo JE, and Roberts WC (1988). Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Card 11:792-799.
2. Barbaro G, Barbarini G, and Di Lorenzo G (1996). Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: A multicenter echocardiographic and echo-Doppler study. AIDS Res Hum Retro 12:1559-1563.
3. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TE, and Klotman PE (1997). Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgenic expression. J Clin Invest 100:84-92.
4. Calabrese LH, Proffitt MR, Yen-Lieberman B, Hobbs RE, and Ratliff NB (1987). Congestive cardiomyopathy and illness related to the acquired immune deficiency syndrome (AIDS) associated with isolation of retrovirus from myocardium. Ann Int Med 107:691-692.
5. Cardoso JS, Moura B, Martins L, Mota-Miranda A, Gonçalves FR, and Lecour H (1998). Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. Int J Cardiol 63:37-45.
6. Chomczynski P and Sacchi N (1987). Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Analyt Biochem 162:156-159.
7. Cocuera Pindado MT, Lopez Bravo A, Martinez-Rodriguez R, Picazo Talavera A, Gomez A, Roldan Contreras M, Perez Alvarez MJ, Fernandez Garcia A, and Alonso Martin MJ (1994). Histochemical and ultrastructural changes induced by zidovudine in mitochondria of rat cardiac muscle. Eur J Histochem 38:311-318.
8. Cohen IS, Anderson DW, Virmani R, Reen BM, Macher AM, Sennesh J, DiLorenzo P, and Redfield RR (1986). Congestive cardiomyopathy in association with the acquired immune deficiency syndrome. N Engl J Med 315:628-630.
9. Coudray N, DeZuttere D, Force G, DeRibes C, Pourny J-C, Antony I, Lecarpentier Y, and Chemla D (1995). Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: An echocardiographic study. Eur Heart J 16:61-67.
10. Currie PF and Boon NA (1983). Cardiac involvement in human immunodeficiency virus infection. Q J Med 86:751-753.
11. Dalakas MC, Illa I, Pezeshkpour G, Laukaitis J, Cohen B, and Griffin J (1990). Mitochondrial myopathy caused by long term zidovudine therapy. N Eng J Med 322:1098-1105.
12. De Palo VA, Millstein BH, Mayo PH, Salzman SH, and Rosen MJ (1995). Outcome of intensive care in patients with HIV infection. Chest 107:506-510.
13. Domanski MJ, Sloas MM, Follmann DA, Scalise PP, Tucker EE, Egan D, and Pizzo PA (1995). Effect of zidovudine and didanosine treatment on heart function in children infected human immunodeficiency virus. J Pediat 127:137-146.
14. Eleftheriades EG, Durand J-B, Ferguson AG, Engelmann GL, Jones SB, and Samarel AM (1993). Regulation of procollagen metabolism in the pressure-overloaded rat heart. J Clin Invest 91:1113-1122.
15. Gerschenson M, Paik CY, Erhart SW, and Poirier MC (1999). Exposure of pregnant patas monkeys to 3'-azido-2',3'-dideoxythymidine (AZT) produces damaged mitochondria and abnormal energy metabolism in the fetal cardiac and skeletal muscle tissues (Abstract). FASEB J A488.
16. Grody WW, Cheng L, and Lewis W (1990). Infection of the heart by the human immunodeficiency virus. Am J Cardiol 66:203-206.
17. Grupp IL, Subramaniam B, Hewett TE, Robbins J, and Grupp G (1993). Comparison of normal, hypodynamic and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol 265:H1401-1410.
18. Herskowitz, A, Willoughby SB, Baughman KL, Schulman SP, and Bartlett JD (1992). Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: A report of 6 cases. Annals Int Med 116:311-313.
19. Hoit BD, Khan ZU, Pawloski-Dahn C, and Walsh RA (1997). In vivo determination of left ventricular shortening and wall stress relationship in normal mice. Am J Physiol 272:H1047-H1052.
20. Hoit BD, Khoury SF, Kranias EG, Ball N, and Walsh RA (1995). In vivo echocardiographic detections of enhanced left ventricular function in gene targeted mice with phospholamban deficiency. Circ Res. 77:632-637.
21. Hsia JA and McQuinn LB (1993). AIDS cardiomyopathy. Res Staff Physician 39:21-24.
22. Jacob AJ, Sutherland GR, Boon NA, and Ludlam CA (1993). Dilated cardiomyopathy in haemophiliacs infected with the human immunodeficiency virus. Scottish Med J 38:112-113.
23. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, and Robbins J (1996). Ablation of the murine (myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 98:1906-1917.
24. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW II, Walsh RA, and Kranias EG (1996). Cardiac specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 97:533-539.
25. Klotman PE and Notkins AL (1996). Transgenic models of human immunodeficiency virus type-1. Curr Top Micro Immun 206:197-222.
26. König H, Behr E, Lower J, and Kurth R (1989). Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase-γ. Antimicrob Agents Chemo 33:2109-2114.
27. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, and Klotman PE (1992). Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. PNAS (USA) 89:1577-1581.
28. Kopp JB, Rooney JF, Wohlenberg C, Dorfman N, Marinos NJ, Bryant JL, Katz SI, Notkins AL, and Klotman PE (1993). Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. AIDS Res Hum Retrovir 9:267-275.
29. Lamperth L, Dalakas MC, Dagani F, Anderson J, and Ferrari R (1991). Abnormal skeletal and cardiac mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest 65:742-751.
30. Lewis W (1998). Mitochondrial toxicity of antiviral nucleosides used in AIDS: Insights derived from toxic changes observed in tissues rich in mitochondria. In: Lipshultz SE, editor. Cardiology in AIDS. New York: Chapman & Hall, 307-316.
31. Lewis W, Chomyn A, Gonzalez B, and Papoian T (1992). Zidovudine induces molecular, biochemical and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 89:1354-1360.
32. Lewis W and Dalakas MC (1995). Mitochondrial toxicity of antiviral drugs. Nature Med 1:417-422.
33. Lewis W, Levine ES, Griniuviene B, Tankersley KO, Colacino JM, Sommadossi, J-P, Watanabe K, and Perrino FW (1996). Fialuridine and its metabolites inhibit DNA polymerase-γ, substitute for thymidine DNA, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. PNAS (USA) 93:3592-3597.
34. Lewis W, Papoian T, Gonzalez B, Louie H, Kelly DP, Payne RM, and Grody WW (1991). Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab Invest 65:228-236.
35. Lewis W, Papoian T, and Kennedy P (1992). Cardiotoxicity of dideoxynucleosides in rats includes morphologically distinct and selective myocardial lesions (Abstract). J Cell Biochem 16E:83.
36. Lewis W, Simpson JF, Colacino JM, Perrino FW, and Meyer RR (1994a). Fialuridine (FIAU) Triphosphate competitively inhibits mitochondrial DNA polymerase-γ. Biochemistry 33: 14620-14624.
37. Lewis W, Simpson JF, and Meyer RR (1994b). Cardiac mitochondrial DNA polymerase-γ is inhibited competitively and non-competitively by phosphorylated zidovudine. Circ Res 74:344-348.
38. Lipshultz SE, Fox CH, Perez-Atayde AR, Sanders SP, Colan SD, McIntosh K, and Winters HS (1990). Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol 66: 246-250.
39. Lipshultz SE, Oray J, Sanders SP, Hale AR, McIntosh K, and Colan SD (1992). Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med 327:1260-1265.
40. McCurdy DT III and Kennedy JM (1996). Skeletal muscle mitochondria from AZT-treated rats have a diminished response to chronic electrical stimulation. J Appl Physiol 81:326-334.
41. McCurdy DT III and Kennedy JM (1998). AZT decreases rat myocardial cytochrome oxidase activity and increases β-myosin heavy chain content. J Mol Cell Cardiol 30:1979-1989.
42. Michael A, Lederman RJ, MacGregor JS, and Cheitlin MD (1997). Cardiovascular involvement in AIDS. Current Prob Cardiol 23:112-148.
43. Reilly JM, Cunnion RE, Anderson, DW, O'Leary TJ, Simmons JT, Lane HC, Fauci, AS, Roberts WC, Virmani R, and Parrillo JE (1988). Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. Am J Cardiol 62:789-793.
44. Ruprecht RM, O'Brien LG, Rosson LD, and Nusinoff-Lehrman S (1986). Suppression of mouse viraemia and retroviral disease by 3'-deoxythymidine. Nature 323:467-469.
45. Spurr AA (1969). A low viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 26:31-43.
46. Swartz MN (1995). Mitochondrial toxicity: New adverse drug effects. N Engl J Med 333:1146-1148.
47. Wallace DC (1999). Mitochondrial disease in man and mouse. Science 283:1482-1488.
48. Wright GE and Brown NC (1990). Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases. Pharmac and Ther 47:447-497.
49. Wu AY, Forouhar, F, Cartan RW, Betrman MM, Shiue ST, Louie AT, and Grunnet M (1990). Identification of human immunodeficiency virus in the heart of a patient with acquired immunodeficiency syndrome. Mod Pathol 3:625-630.